StockData
20/20 Biolabs, Inc. logo

20/20 Biolabs, Inc. (AIDX) stock

AIDXNasdaqServices-Testing LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/3068% below fair value
$0.19−0.00 (-1.01%)

Close on Nov 18, 2026Market cap $2.37MP/E –Yield –

20/20 Biolabs shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

20/20 Biolabs's shares outstanding was 11M at Jun 30, 2026. For fiscal 2025 it was 5M, up 2.7% from the year before.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 20255M+2.7%
FY2024Dec 31, 20245M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202611M–
Q1 FY2026Mar 31, 20268M–
Q2 FY2025Jun 30, 20255M–
Q1 FY2025Mar 31, 20255M–

More 20/20 Biolabs figures

See a number that looks wrong?